GeneNews Launches World’s First Blood Test For Colorectal Cancer Screening
GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, announced the launch of ColonSentry(TM), the world’s first blood-based molecular test for colorectal cancer screening.
More: continued here
Filed under: Blood on July 22nd, 2008